Frequency of daily over-the-counter drug use and potential clinically significant over-the-counter-prescription drug interactions in the Finnish adult population
S. Sihvo et al., Frequency of daily over-the-counter drug use and potential clinically significant over-the-counter-prescription drug interactions in the Finnish adult population, EUR J CL PH, 56(6-7), 2000, pp. 495-499
Objective: To explore the frequency of continuous use of over-the-counter (
OTC) drugs among the Finnish adult population and the potential for harmful
interactions between OTC drugs and prescribed (Rx) drugs.
Methods: Data were extracted from a 1995-1996 population-based interview su
rvey on health care (n = 10,477, response rate 86%). The drug interaction c
lassification system from the Swedish Drug Compendium FASS 1997 was used to
identify OTC drugs likely to have clinically significant interactions with
prescription drugs. Logistic regression was used to study factors related
to continuous use and risks for interactions.
Results. Seventeen percent of the population had used OTC drugs and 15% had
used OTC vitamins during the 2 days prior to the interview. Daily use of O
TC drugs and of vitamins was reported by 7% and 9%, respectively. Continuou
s use of OTC drugs was related to older age, female gender, higher educatio
n, poor health status, long-term morbidity, psychosomatic symptoms (fatigue
) and use of prescription drugs, but not to poor lifestyle. Four percent of
the OTC drug users had taken drug combinations with potential for clinical
ly significant interactions. Interactions were most common for ketoprofen (
15% of ketoprofen users), ibuprofen (10%), and acetylsalicylic acid (ASA) (
6%). The number of prescription drugs, long-term illness and lower educatio
n best explained the risk for interactions.
Conclusion: Continuous use and potentially harmful Rx/OTC drug interactions
occur among OTC drug, users. Further studies should be done to investigate
whether potential combinations will actually lead to clinical problems. Th
e possible interactions of non-steroidal anti-inflammatory drugs (NSAIDs) a
nd analgesics with prescription drugs should especially be taken into accou
nt in drug information.